Corner Stitch: Acing the final training years

In academia, the start of summer brings about new beginnings and a changing of the guard. Chief residents and senior fellows graduate and start new jobs. This month, we decided to pick some of their brains to share their lived…
Medicare: Surgical Care Coalition urges Congress to halt proposed cuts to care

The proposed Medicare Physician Fee Schedule for calendar year 2022 (CY2022) released Tuesday by the Centers for Medicare & Medicaid Services (CMS) fails to address pending cuts to surgical care “and therefore continues to threaten patient care by reaffirming these…
The vasculature united: Bringing together competing specialties for better patient care

Incoming Society for Vascular Surgery (SVS) President Ali AbuRahma, MD, knows the topic of this year’s E. Stanley Crawford Critical Issues Forum at the Vascular Annual Meeting (VAM) might make him as many enemies as it will friends. “You are…
#SVSTweetChat hits high levels of engagement

Since the inaugural #SVSTweetChat that covered early career advice went live on Twitter in April, the monthly social media initiative has proven to be a valuable and interactive resource for the vascular surgeon community. It even inspired an episode of…
Final Meet the Experts session is July 15

Practicing vascular surgeons, learn all about preventing and managing type II endoleaks—a common situation faced by specialists—from the experts on Thursday, July 15. Benjamin Jackson, MD, will moderate the session, alongside panelists Wei Zhou, MD, and Sunita Srivastava, MD. Participation…
WFVS undergoes transformation, looks for vascular ’haves‘ to better help ‘have nots‘

The World Federation of Vascular Societies (WFVS) has entered a new era of transformation, seeking to better pave the way for disparate vascular surgeons and societies to disseminate the latest science and best practices to every corner of the globe.…
Town Halls to address wellness, appropriate use

The Society for Vascular Surgery (SVS) has scheduled two Town Halls for the summer—one to cover vascular surgeon wellness programs (July 13) and the other to discuss the SVS’ first-ever appropriate use criteria (AUC) guidelines being developed on intermittent claudication…
Fighting the good fight: The case for multidisciplinary limb salvage in face of increasing diabetes, diversifying nation

Dramatic increases in rates of diabetes—particularly among Black females—through 2060 underscore the importance of a multidisciplinary team approach to limb salvage, according to Vincent Rowe, MD, professor of vascular surgery and endovascular therapy in the Keck School of Medicine at…
Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical

Surmodics recently announced that it has acquired privately-held Vetex Medical Limited, expanding the company’s thrombectomy portfolio with a second Food and Drug Administration (FDA) 510(k)-cleared device, the ReVene thrombectomy catheter. The ReVene mechanical thrombectomy catheter is specifically designed to remove large,…
Janssen submits new drug application to FDA for rivaroxaban to treat VTE in pediatric patients

The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced it has submitted a new drug application (NDA) to the Food and Drug Administration (FDA) for the use of Xarelto (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment…

